They have four in Phase II. Many patients have stable disease or are in remission. I think with a market cap of $21 million with $5 million in the bank, we are hardly getting carried away. Inhibitex is in stage II. What were they worth? $2.5 billion
Add to My Watchlist
What is My Watchlist?